Pall Launches New Fluid Management Technologies for the Biopharmaceutical Industry at INTERPHEX2007

Business Wire, April 25, 2007

EAST HILLS, N.Y. -- The increasing focus on biotechnology and personalized medicines along with the growth of the vaccine marketplace is changing the face of the biopharmaceutical industry, an $80 billion global market. Drug manufacturers are challenged by cost pressures, the need for shorter production times and rapid scale-up, as well as bottlenecks in downstream operations. At INTERPHEX2007, Pall Corporation (NYSE:PLL) launches several new technologies to provide the biopharmaceutical industry with tools and systems to more efficiently manage their manufacturing processes. A leader in filtration, separation and purification, Pall offers a comprehensive line of integrated solutions for biopharmaceutical manufacturers from upstream to downstream applications.

"In the rapidly changing biopharmaceutical market, manufacturers must be able to adapt quickly and effectively to sustain leadership," says Ken Frank, President, Pall BioPharmaceuticals. "Our strong global presence and deep portfolio of cutting-edge technologies provide customers with comprehensive systems to help them efficiently optimize their drug production processes."

Pall continues to champion the implementation of disposable processing with the launch of its Allegro(TM) Systems, an integrated single-use manufacturing solution, and its newest component, the Allegro Biocontainers for collection and transport of process solutions, product intermediates and cell culture media. Single-use technologies, employed by more than 90 percent of biopharmaceutical manufacturers, provide cost, flexibility and quality benefits. They increase efficiency by eliminating the need for cleaning and cleaning validation and reduce cross-contamination risks.

Pall Allegro Systems are gamma-irradiated and ready-for-use, facilitating quick start-up and rapid scale-up to help accelerate time-to-market. These qualities are becoming increasingly essential for the production of biotech drugs and vaccines as well as for contract manufacturing organizations.

The new Allegro Biocontainers feature a unique combination of design and materials that help manufacturers maximize product recovery and minimize risk of contamination. The comprehensive Allegro Systems portfolio includes disposable filters, tubing and instant aseptic connection devices in addition to the new biocontainers.

With the new disposable Kleenpak(TM) TFF Microfiltration Capsule, Pall is introducing the industry's first tangential flow filtration capsule. Tangential flow filtration is used for clarifying, concentrating and purifying proteins. A self-enclosed capsule, the Kleenpak TFF capsule helps improve worker safety by limiting exposure to biologically active solutions. This is an important consideration for manufacturers of vaccines and other potent products that present potential workplace liabilities.

To address the processing bottlenecks caused by higher protein throughput, Pall strengthens its line of ultrafiltration technologies with the introduction of the Omega[TM] T- Series Membrane Cassettes. The new cassettes are constructed with high performance materials that reduce extractables and assure effective mass transfer of proteins to deliver high-purity biological solutions. The advanced filtration performance of the Omega T-Series cassettes is also available in a disposable capsule format through the Minimate(TM) II Capsule. This product easily scales with products in Pall's extensive line of cassette technologies for truly integrated operations.

About Pall Corporation

Pall Corporation is the global leader in the rapidly growing field of filtration, separation and purification. Pall is organized into two businesses: Life Sciences and Industrial. These businesses provide leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceutical, transfusion medicine, energy, electronics, municipal and industrial water purification, aerospace, transportation and broad industrial markets. Total revenues for fiscal year 2006 were $2.0 billion. The Company headquarters is in East Hills, New York with extensive operations throughout the world. For more information visit Pall at www.pall.com.

Editor's Notes:

* Pall's technologies are on display at INTERPHEX2007 booth # 1819, at the Jacob K. Javits Convention Center, New York, NY, April 24-26, 2007.

* Pall is hosting a press luncheon on Wednesday, April 25, 2007 at 12:00pm in room 1A18 at the Javits Convention Center.

* Downloadable, high-resolution images are available at http://www.pall.com/corporate_42872.asp.>

COPYRIGHT 2007 Business Wire

COPYRIGHT 2008 Gale, Cengage Learning